✦ LIBER ✦

Pivotal phase III trial of two dose levels of DAB389IL-2 (ontak™) for the treatment of cutaneous T-cell lymphoma (CTCL)

✍ Scribed by Olsen, EA; Duvic, M; Martin, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bexarotene and DAB389IL-2 (Denileukin Di

✍ Duvic, Madeleine 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 440 KB

Topical bexarotene therapy for patients

✍ Peter Heald; Marilyn Mehlmauer; Ann G Martin; Constance A Crowley; Richard C Yoc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 328 KB

A phase II trial of individualized respo

✍ Shinbo, T; Makino, M; Tsukada, H; Yokoyama, A; Saitou, M; Kurita, Y 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 230 KB